Research Paper
Year: 2021 | Month: July | Volume: 8 | Issue: 7 | Pages: 99-104
DOI: https://doi.org/10.52403/ijrr.20210714
Relationship between Plasma Vascular Endothelial Growth Factor (VEGF) and Ovarian Cancer Staging
Erma Wahyuni1, Herman Hariman1, Deri Edianto2
1Department of Clinical Pathology, Faculty of Medicine, Universitas Sumatera Utara / Haji Adam Malik General Hospital, Medan, North Sumatera
2Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Sumatera Utara / Haji Adam Malik General Hospital, Medan, North Sumatera
Corresponding Author: Erma Wahyuni
ABSTRACT
Ovarian cancer is the 8th most common cancer that occurs in most women. In a 2018 survey by Global Cancer Statistics in 185 countries of all cancer cases, 3.4% were caused by ovarian cancer. Vascular endothelial growth factor is a multifunctional cytokine that stimulates angiogenesis and increases microvascular permeability by binding to receptors located in endothelial cells in blood vessels. Immature platelet fraction (% IPF) is a modern parameter that measures young platelets and reticulation in peripheral blood. The purpose of this study was to look at differences in plasma VEGF and IPF levels between ovarian cancer sufferers and staging of ovarian cancer. This type of research is a cross sectional observational study of VEGF and Ovarian Cancer stage. A total of 18 people with ovarian cancer were sampled before surgery and after surgery an anatomy pathology examination was performed to assess early stage and advanced cancer staging. From 18 patients with ovarian cancer obtained from the early stage ovarian cancer group and advanced stage group. Obtained a median age of 50 (42-63), whereas in the advanced stage group a median age of 51 (19-68) was obtained. There is a significant difference between VEGF levels in early and advanced stage ovarian cancer with a value of p = 0,000. Using the Spearman Correlation test to assess the correlation between tumor size and VEGF levels, p values <0.001 with r = 0.742 were obtained. The conclusion of this research are advanced stage ovarian cancer VEGF is significantly higher P = 0.001 compared to early stage.
Keywords: VEGF, Ovarian Cancer.
[PDF Full Text]